Characterizing SARS-CoV-2 infection of human taste cells in culture
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20152020Known Financial Commitments (USD)
$174,487Funder
National Institutes of Health (NIH)Principal Investigator
ROBERT F MARGOLSKEEResearch Location
United States of AmericaLead Research Institution
MONELL CHEMICAL SENSES CENTERResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
AbstractRelatedness of Supplement Aim to Parent GrantIn the parent grant, we use cultured human taste (HBO) cells, pioneered at Monell by Co-Investigator HakanOzdener, to probe the metabolic sweet taste signaling pathway. HBO cells provide a useful model for probingtaste signaling in culture, but they have also been shown useful for investigating the pathophysiology of certainneurotrophic viral diseases (e.g. Zika virus; see Ozdener et al., 2020). Using HBO cells to accomplish theSupplement Aim will advance our understanding of the pathogenicity of SARS-CoV-2 and other viruses thatadversely affect taste and olfaction. Although many studies have reported taste and olfactory loss in individualswith COVID-19 disease, the underlying mechanisms and cellular effects in taste cells are not well understood.Due to changes in taste function in patients with COVID-19, it will be of particular interest to the parent grant toknow if the subset of sweet taste cells is susceptible to infection by SARS-CoV-2.